Mobile team vs. lab: which HPV screening strategy works best for women with HIV?

NCT ID NCT07181278

First seen Nov 01, 2025

Summary

This study looks at two ways to screen for cervical cancer in women with HIV in Cameroon. One way sends self-collected samples to a central lab; the other uses a mobile team that tests and treats on the spot. Researchers want to see which approach helps more women complete all screening steps. About 1,180 women aged 25 to 49 will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bafoussam Baptist Hospital

    RECRUITING

    Bafoussam, Cameroon

    Contact

  • Bandjoun District Hospital

    RECRUITING

    Bandjoun, Cameroon

    Contact

  • Bingo Hospital

    RECRUITING

    Bafoussam, Cameroon

    Contact

  • Centre Médical Spécialisé ACHA

    RECRUITING

    Bafoussam, Cameroon

    Contact

  • Foumbot District Hospital

    RECRUITING

    Foumbot, Cameroon

    Contact

  • Hôpital Régional Annexe

    RECRUITING

    Bafoussam, Cameroon

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could show that a mobile team offering same-day HPV testing and treatment is more effective than sending samples to a central lab, helping more women complete screening.

What could go wrong

This is an observational study comparing two existing strategies, not testing a new treatment. Results may not apply to other regions or populations.

Conditions

The condition(s) this trial relates to.

HIV infectious disease Uterine Cervical Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.